Pharming (PHAR) Debt Ratio (2019 - 2024)

Pharming (PHAR) has 8 years of Debt Ratio data on file, last reported at 0.2 in Q2 2026.

• Quarterly Debt Ratio fell 3.46% year-over-year to 0.2 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.2 (down 3.46% YoY) and the FY2025 annual result came in at 0.19, up 154.98% from the prior year.
• Debt Ratio advanced to 0.2 in Q2 2026, from 0.19 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.35 in Q1 2022 to a low of 0.32 in Q3 2024.
• A 5-year average of 0.17 and a median of 0.2 in 2025 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 43996211.97% — and 2024, when it slumped 206.68%.
• Tracing PHAR's Debt Ratio over 5 years: stood at 0.0 in 2022, then dropped by 5.09% to 0.0 in 2023, then surged by 169.31% to 0.01 in 2024, then soared by 1647.42% to 0.19 in 2025, then grew by 6.47% to 0.2 in 2026.
• The last three Debt Ratio figures came in at 0.2 (Q2 2026), 0.19 (Q1 2026), and 0.19 (Q4 2025), per Business Quant data.